Heart disease causes one in four American deaths every year. Edwards Lifesciences, which creates artificial heart valves, including for patients deemed too risky for open surgery, has significantly expanded its international footprint and shows no signs of slowing down. The most promising growth avenue is among lower-risk patients who require noninvasive heart valve replacements.
Subscribe to Fortune’s Brainstorm Health Daily newsletter, where we monitor advances in healthcare and biopharma.
Health Care Equipment and Supplies
|Revenues ($M) (Past 12 Months)||$3,964|
|Profits ($M) (Past 12 Months)||$725|
|Market Value as of Oct. 9, 2019 ($M)||$46,754|
Refinitiv Sustainable Leadership Monitor
The Sustainable Leadership Monitor is independent and separate from BCG and the Future 50.